FDA Inspection 1055147 — Clareblend, Inc.

Clareblend, Inc. — FEI 2020958

The FDA completed an inspection of Clareblend, Inc. on Jun 8, 2018 in Reno, NV. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 11 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 8, 2018
Fiscal Year
2018
Product Type
Devices
Project Area
Compliance: Devices
Location
Reno, NV (United States)

Citations

IDCFRDescription
1472221 CFR 820.40Procedures not adequately established or maintained
232721 CFR 820.22Quality audits - Lack of or inadequate procedures
313221 CFR 820.120Lack of or inadequate procedures for labeling
314921 CFR 820.180Availability
315921 CFR 820.184DHR content
316821 CFR 820.198(a)Complaints
323321 CFR 820.72(a)Calibration, Inspection, etc. Procedures Lack of or Inadequ
328221 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures
333121 CFR 820.181DMR - not or inadequately maintained
342621 CFR 820.50(a)(1)Documented evaluation
369621 CFR 820.100(b)Documentation